The Latest Breaking News from Petco

Amazon handily beat Walmart for the lowest prices on food and consumables, a study shows. In other categories, things tightened up.

Companies are hiring anti-union consultants and deploying hardball tactics when workers threaten to form a union

Despite lingering supply chain disruptions, the retail industry is expected to benefit from strong consumer demand and accelerated digital transformation. Certain retail companies recorded better-than-expected quarterly earnings in their last reported quarters. So, considering their strong financials and solid growth prospects, we think it could be wise to invest in…

A valued certification for humane animal care awarded to Petco Health & Wellness in March is now under attack by PETA, which contends it amounts to false advertising.

The future of e-commerce could be coming to a local mall near you.

Despite rising pet care costs amid the Russia-Ukraine war and record-high inflation, the demand for pet care products remains strong. And because a significant increase in pet ownership amid the COVID-19 pandemic is expected to keep the demand high, we think it could be wise to scoop up shares of…

Needham analyst Anna Andreeva gave Petco Health And Wellness Co Inc (NASDAQ:WOOF) a Buy rating with a price target of $30.00 (45% upside). Andreeva notes Petco is becoming an omni-channel powerhouse after revamping its digital capabilities under CEO Ron Coughlin. The analyst thinks that the company’s bundled offerings model has a significant advantage over digital-only players. Petco…

ATLANTA — Back during my son's two-year fight against an aggressive bone cancer, he was continually devastated by chemo treatments and the ensuing nausea. The doctors were always chasing that nausea, prescribing one drug after another for relief, a routine that was very hit and miss. Often miss.

Growing Western sanctions on Russia could cause further industrial supply disruptions. In addition, crude oil prices have been skyrocketing. Therefore, many analysts are forecasting the emergence of a recessionary environment. Given this backdrop, we think it could be wise to bet on defensive stocks Vertex Pharmaceuticals (VRTX), Ambev (ABEV), AmerisourceBergen…